Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R)
- PMID: 33094623
- PMCID: PMC8603737
- DOI: 10.33549/physiolres.934512
Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R)
Abstract
Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.
Conflict of interest statement
There is no conflict of interest.
Similar articles
-
Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.Trends Mol Med. 2019 Feb;25(2):136-148. doi: 10.1016/j.molmed.2018.12.002. Epub 2019 Jan 11. Trends Mol Med. 2019. PMID: 30642682 Review.
-
Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.Life Sci. 2022 Oct 15;307:120857. doi: 10.1016/j.lfs.2022.120857. Epub 2022 Aug 2. Life Sci. 2022. PMID: 35931197
-
Treatment options for children with monogenic forms of obesity.World Rev Nutr Diet. 2013;106:105-12. doi: 10.1159/000342556. Epub 2013 Feb 11. World Rev Nutr Diet. 2013. PMID: 23428688 Review.
-
Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.J Clin Endocrinol Metab. 2018 Jul 1;103(7):2601-2612. doi: 10.1210/jc.2018-00258. J Clin Endocrinol Metab. 2018. PMID: 29726959 Free PMC article.
-
MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.J Clin Endocrinol Metab. 2024 Sep 16;109(10):2452-2466. doi: 10.1210/clinem/dgae210. J Clin Endocrinol Metab. 2024. PMID: 38567654 Free PMC article.
Cited by
-
Induction of Accelerated Aging in a Mouse Model.Cells. 2022 Apr 22;11(9):1418. doi: 10.3390/cells11091418. Cells. 2022. PMID: 35563724 Free PMC article. Review.
-
Effects of Anterior Pituitary Adenomas' Hormones on Glucose Metabolism and Its Clinical Implications.Diabetes Metab Syndr Obes. 2023 Feb 13;16:409-424. doi: 10.2147/DMSO.S397445. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 36816815 Free PMC article. Review.
-
Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics.Molecules. 2023 Aug 31;28(17):6375. doi: 10.3390/molecules28176375. Molecules. 2023. PMID: 37687205 Free PMC article. Review.
-
Development of Melanocortin 4 Receptor Agonists by Exploiting Animal-Derived Macrocyclic, Disulfide-Rich Peptide Scaffolds.ACS Pharmacol Transl Sci. 2023 Sep 26;6(10):1373-1381. doi: 10.1021/acsptsci.3c00090. eCollection 2023 Oct 13. ACS Pharmacol Transl Sci. 2023. PMID: 37854631 Free PMC article.
-
Genes in human obesity loci are causal obesity genes in C. elegans.PLoS Genet. 2021 Sep 7;17(9):e1009736. doi: 10.1371/journal.pgen.1009736. eCollection 2021 Sep. PLoS Genet. 2021. PMID: 34492009 Free PMC article.
References
-
- ADAMSKA-PATRUNO E, GOSICK J, CZAJOWSKI P, MALISZEWSKA K, CIBOROWSKI M, GOLONKO A, WAVRUSIEWICZ-KURYLONEK N, CITKO A, WASZCZENIUK M, KRETOWSKI A, GORSKA M. The MC4R genetic variants are associated with lower visceral fat accumulation and higher postprandial relative increase in carbohydrate utilization in humans. Eur J Nutr. 2019;58:2929–2941. doi: 10.1007/s00394-019-01955-0. - DOI - PMC - PubMed
-
- AYERS KL, GLICKSBERG BS, GARFIELD AS, LONGERICH S, WHITE JA, YANG P, DU L, CHITTENDEN TW, GULCHER JR, ROY S, FIEDOREK F, GOTTESDIENER K, COHEN S, NORTH KE, SCHADT EE, LI SD, CHEN R, Van der PLOEG LHT. Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment. J Clin Endocrinol Metab. 2018;103:2601–2612. doi: 10.1210/jc.2018-00258. - DOI - PMC - PubMed